"Gynaecological and obstetric management of women with inherited bleeding disorders ED - Lawn Joy E; Darmstadt Gary L; Goldenberg Robert L", INTERNATIONAL JOURNAL OF GYNECOLOGY AND OBSTETRICS, NEW YORK, NY, US, vol. 95, no. 1, 1 October 2006 (2006-10-01), pages 75-87, XP028069779, ISSN: 0020-7292, DOI: 10.1016/J.IJGO.2006.02.004 [retrieved on 2006-10-01] (B1)

ATTARDI BARBARA J ET AL: "CDB-4124 and its putative monodemethylated metabolite, CDB-4453, are potent antiprogestins with reduced antiglucocorticoid activity: In vitro comparison to mifepristone and CDB-2914" MOLECULAR AND CELLULAR ENDOCRINOLOGY, ELSEVIER IRELAND LTD, IE, vol. 188, no. 1-2, 25 February 2002 (2002-02-25), pages 111-123, XP002496575 ISSN: 0303-7207 (B1)

ATTARDI BARBARA J ET AL: "In vitro antiprogestational/antiglucocorticoid activity and progestin and glucocorticoid receptor binding of the putative metabolites and synthetic derivatives of CDB-2914, CDB-4124, and mifepristone", JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, ELSEVIER SCIENCE LTD., OXFORD, GB, vol. 88, no. 3, 1 March 2004 (2004-03-01), pages 277-288, XP009115739, ISSN: 0960-0760, DOI: 10.1016/J.JSBMB.2003.12.004 (B1)

CHWALISZ K ET AL: "Selective progesterone receptor modulator development and use in the treatment of leiomyomata and endometriosis" ENDOCRINE REVIEWS 200505 US, vol. 26, no. 3, May 2005 (2005-05), pages 423-438, XP002527456 ISSN: 0163-769X (B1)

ERIKCI ALEV AKYOL ET AL: "Recombinant activated factor VII for severe uterine bleeding after chemotherapy in a woman with acute myeloid leukemia" BLOOD COAGULATION & FIBRINOLYSIS, vol. 17, no. 4, June 2006 (2006-06), pages 323-324, XP008106077 ISSN: 0957-5235 (B1)

ERIKCI ALEV AKYOL ET AL: "Recombinant activated factor VII for severe uterine bleeding after chemotherapy in a woman with acute myeloid leukemia", BLOOD COAGULATION & FIBRINOLYSIS, RAPID COMMUNICATIONS, OXFORD, OXFORD, GB, vol. 17, no. 4, 1 June 2006 (2006-06-01), pages 323-324, XP008106077, ISSN: 0957-5235, DOI: 10.1097/01.MBC.0000224854.88366.05 (B1)

WO-A-96/23503 (B1)

MUNRO M G: "Abnormal uterine bleeding in the reproductive years. Part II - Medical management" JOURNAL OF THE AMERICAN ASSOCIATION OF GYNECOLOGIC LAPAROSCOPISTS 200002 US, vol. 7, no. 1, February 2000 (2000-02), pages 17-35, XP008106083 ISSN: 1074-3804 (B1)

MUNRO M G: "Medical management of abnormal uterine bleeding" OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA 2000 US, vol. 27, no. 2, 2000, pages 287-304, XP008106082 ISSN: 0889-8545 (B1)

PASSARO MAUREEN D ET AL: "Luteal phase dose-response relationships of the antiprogestin CDB-2914 in normally cycling women." HUMAN REPRODUCTION (OXFORD, ENGLAND) SEP 2003, vol. 18, no. 9, September 2003 (2003-09), pages 1820-1827, XP002527457 ISSN: 0268-1161 (B1)

SPITZ IRVING M: "Progesterone receptor antagonists" CURRENT OPINION IN INVESTIGATIONAL DRUGS, PHARMAPRESS, US, vol. 7, no. 10, 1 October 2006 (2006-10-01), pages 882-890, XP009110067 ISSN: 1472-4472 (B1)

WO-A-2006/010097 (B1)

MILLER J ET AL: "Abnormal uterine bleeding: A primary care primer" CONSULTANT 2005 US, vol. 45, no. 6, 2005, pages 638-645, XP008106081 ISSN: 0010-7069 (B1)